Clinical Research Directory
Browse clinical research sites, groups, and studies.
Intravenous Thrombosis and Patients with Prior Ischemic Stroke Within 3 Months
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University
Summary
The primary hypothesis being tested in this trial is that ischemic stroke patients with prior ischemic stroke within 3 months will have improved clinical outcomes when given intravenous thrombolysis compared to standard care.
Official title: Intravenous Thrombosis in Acute Ischemic Stroke Patients with Prior Ischemic Stroke Within 3 Months
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
306
Start Date
2025-03-01
Completion Date
2027-12-31
Last Updated
2025-02-24
Healthy Volunteers
No
Conditions
Interventions
Intravenous Thrombolysis
Patients will receive standard dose intravenous alteplase (0.9 mg/kg, the first 10% administered as an initial bolus and the remainder over a 1-hour period, with a maximum dose of 90 mg),intravenous Tenecteplase(0.25mg/kg,administered as a single intravenous bolus injection over 5 - 10 seconds,with a maximum dose of 25 mg), intravenous reteplase (a bolus of 18 mg followed by a second bolus of 18 mg after 30 minutes) and intravenous prourokinase (rhPro-UK) (15 mg bolus followed by a 20 mg infusion over 30 minutes).